Why is target trial emulation not being used in health technology assessment real-world data submissions?

被引:0
|
作者
Castanon, Alejandra [1 ]
Duffield, Stephen [2 ]
Ramagopalan, Sreeram [1 ]
Reynolds, Robert [3 ]
机构
[1] Lane Clark & Peacock LLP, London W1U 1DQ, England
[2] Natl Inst Hlth Care Excellence, Manchester M1 4BT, Lancs, England
[3] GSK, New York, NY USA
关键词
health technology assessment; observational data; randomized controlled trials; real-world data; target trial emulation;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Real-World Evidence: A Review of Real-World Data Sources Used in Orthopaedic Research
    Hak, David J.
    Mackowiak, John I.
    Irwin, Debra E.
    Aldridge, Molly L.
    Mack, Christina D.
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2021, 35 : S6 - S12
  • [42] Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward
    Akehurst, Ron
    Murphy, Linda A.
    Sola-Morales, Oriol
    Cunningham, David
    Mestre-Ferrandiz, Jorge
    de Pouvourville, Gerard
    VALUE IN HEALTH, 2023, 26 (04) : 11 - 19
  • [43] Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward
    Lou, Jing
    Sarin, K. C.
    Toh, Kai Yee
    Dabak, Saudamini
    Adler, Amanda
    Ahn, Jeonghoon
    Bayani, Diana Beatriz S.
    Chan, Kelvin
    Choiphel, Dechen
    Chua, Brandon
    Genuino, Anne Julienne
    Guerrero, Anna Melissa
    Kearney, Brendon
    Lin, Lydia Wenxin
    Liu, Yuehua
    Nakamura, Ryota
    Pearce, Fiona
    Prinja, Shankar
    Pwu, Raoh-Fang
    Shafie, Asrul Akmal
    Sui, Binyan
    Suwantika, Auliya
    Teerawattananon, Yot
    Tunis, Sean
    Wu, Hui-Min
    Zalcberg, John
    Zhao, Kun
    Isaranuwatchai, Wanrudee
    Wee, Hwee-Lin
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (05) : 474 - 480
  • [44] POLICIES FOR USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT: A COMPARATIVE STUDY OF 6 HTA AGENCIES
    Makady, A.
    ten Ham, R.
    de Boer, A.
    Hillege, J. L.
    Klungel, O.
    Goettsch, W.
    VALUE IN HEALTH, 2016, 19 (07) : A501 - A502
  • [45] Transferability of real-world data across borders for regulatory and health technology assessment decision-making
    Jaksa, Ashley
    Arena, Patrick J.
    Chan, Kelvin K. W.
    Ben-Joseph, Rami H.
    Jonsson, Pall
    Campbell, Ulka B.
    FRONTIERS IN MEDICINE, 2022, 9
  • [46] The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment Author's Reply
    Patel, Dony
    van Engen, Anke
    Kim, Joseph
    VALUE IN HEALTH, 2022, 25 (07) : 1256 - 1256
  • [47] COMBINING CLINICAL TRIAL AND REAL-WORLD EVIDENCE DATA IN THE ASSESSMENT OF PUBLIC HEALTH IMPACT IN HTA EVALUATIONS
    Leleu, H.
    Nucit, A.
    Lefevre, C.
    Salvignol, O.
    Grenier, B.
    Coulibaly, C.
    Jolivel, R.
    Blachier, M.
    VALUE IN HEALTH, 2022, 25 (01) : S198 - S198
  • [48] REAL-WORLD EVIDENCE (RWE) TO SUPPORT REGULATORY SUBMISSIONS: LANDSCAPE ASSESSMENT & REVIEW
    Haris, G.
    Acha, V
    Liu, S.
    Burcu, M.
    VALUE IN HEALTH, 2023, 26 (06) : S213 - S213
  • [49] "Real-World" Evidence, Target Trial Emulation, and Randomized Clinical Trials-Which Data Should Clinicians Rely on When Choosing Antibiotics?
    Paterson, David L.
    Sulaiman, Helmi bin
    JAMA NETWORK OPEN, 2024, 7 (01)
  • [50] Target trial emulation with real-world data to determine the population-level costeffectiveness of multi-gene panel sequencing in advanced melanoma
    Krebs, Emanuel
    Weymann, Deirdre
    Ho, Cheryl
    Pollard, Samantha
    Regier, Dean A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)